I prefer diversified high risk, high reward investing. Biotechs are a current favorite. In 2014, up 34.5% (117 times the S&P), and Stocktwits is a big reason. Happy with the result, but still cautious.
I am a full-time trader who uses both technical and fundamental evaluations to pick my portfolio. I prefer growth strategies, but employ safer strategies when market direction dictates this.